Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28
Global donors at the 2023 Reaching the Last Mile Forum today pledged a collective US$777.2 million to help control, eliminate, and eradicate neglected tropical diseases (NTDs), in a landmark push to accelerate progress towards achieving the goals outlined in the World Health Organization’s 2030 roadmap on NTDs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231203773888/en/
Uniting efforts with NTD-endemic countries, donors answered the urgent call to step up the fight against NTDs in the face of climate change, and to work together to improve the lives of the 1.6 billion people worldwide affected by these devastating yet preventable diseases.
The pledging event was hosted by Reaching the Last Mile (RLM), the global health initiative driven by the philanthropy of His Highness Sheikh Mohamed Bin Zayed Al Nahyan, President of the UAE, in partnership with the Bill & Melinda Gates Foundation. The forum took place on the first ever Health Day during the United Nations Climate Change Conference (COP28).
His Highness Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs, UAE, was joined by world leaders including H.E. Samia Suluhu Hassan, President of Tanzania; and H.E. Dr Austin Demby, Minister of Health and Sanitation, Sierra Leone, in a demonstration of endemic country leadership against NTDs.
Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, and His Highness Sheikh Theyab bin Mohamed Al Nahyan, Chairman of the Office of Development Affairs at the UAE’s Presidential Court, which oversees Reaching the Last Mile, were also in attendance, alongside ministers and global health leaders.
His Highness Sheikh Abdullah bin Zayed Al Nahyan stated: “The UAE is proud to host this pivotal conference and expresses gratitude to all those who have seized the opportunity to renew their commitment to end neglected tropical diseases. Today’s demonstration of global solidarity reflects a shared determination to deliver a better and more dignified future for all. Incredible progress over the last two decades has proved that a world free of NTDs is an achievable goal. We warmly thank governments, donors, and partners for standing with us as we strive to achieve it.”
Reaching the Last Mile joined with the Gates Foundation and global partners to announce a milestone expansion of the Reaching the Last Mile Fund (RLMF) from $100m to $500m. The expansion will increase the reach of the fund from seven countries to 39 across Africa and Yemen, with the audacious goal of eliminating two NTDs, lymphatic filariasis and onchocerciasis (river blindness), from the continent of Africa.
The funding builds on the pioneering success of the RLMF, which launched in 2017 as a 10-year, multi-donor fund, to establish a model for eliminating the two diseases in sub-Saharan Africa.
His Highness Sheikh Theyab bin Mohamed Al Nahyan said: “Today we reaffirm our pledge to eliminate these diseases of poverty, and save and improve lives worldwide. Climate change is already affecting the patterns of infectious diseases and risking the tremendous gains countries have made to date.
“With endemic countries leading the way, the Reaching the Last Mile Fund represents a historic opportunity to free communities across Africa from the threat of two NTDs, and in partnership unlock the potential for a healthier world.”
“Climate change is inextricably linked to poverty and diseases affecting millions,” said Bill Gates, Co-chair of the Bill & Melinda Gates Foundation. “That is why funding for lifesaving healthcare is critical and why we’re joining global partners to build on the tremendous progress of the Reaching the Last Mile Fund to date, and accelerate the elimination of LF and river blindness across Africa and beyond.”
Reaching the Last Mile’s new $100m commitment, matching the Gates Foundation’s $100m commitment, represents a five-fold increase over the contributions made, respectively, to the fund at its launch.
Further contributions from country and donor partners including Sierra Leone, the Carter Center, Sightsavers, the Children’s Investment Foundation Fund (CIFF), The Helmsley Charitable Trust, the END Fund, and Abu Dhabi National Insurance Company will see RLMF significantly broaden its scope, with the aim of ensuring over 350 million people no longer require treatment for these diseases by 2030.
H.E. Julius Maada Bio, President of Sierra Leone, said: “There is clarity of vision as well as growing demand and energy in Africa to see the continent free of NTDs. Political commitment has been sustained and energised through the Kigali Declaration, and through the Continental Framework and Common Africa Position on NTDs, which Sierra Leone is proud to have endorsed. That is why Sierra Leone is proud to pledge towards an Africa free of river blindness and lymphatic filariasis. Neglected tropical diseases cause suffering to millions, and we simply cannot afford to neglect them any longer.”
H.E. Samia Suluhu Hassan, President of Tanzania, said: "I am immensely proud to have been at the centre of the launch of this ambitious vision of an Africa free of river blindness and lymphatic filariasis. Tanzania commits to increase domestic contribution for combating NTDs but also counts on continued support from development partners in this endeavor.
"While gaps in global funding for NTDs remain, this initiative signifies a crucial step forward in enhancing the health and quality of life not just for Tanzanians, but for all who live on the African continent. Together, we can end these terrible diseases, forging a path to a healthier and brighter future for us all."
Over five years the RLMF has provided over 100 million treatments, trained 1.3 million health workers, and established nine laboratories to support NTD surveillance and testing. The fund also played a critical role in interrupting the transmission of river blindness in Niger, an achievement once thought to be scientifically impossible in Africa, and has supported Senegal in nearing this milestone.
The wider pledging moment saw new, multimillion-dollar commitments made by organizations including the Anesvad Foundation, CIFF, USAID, Global Health EDCTP3, UBS Optimus Foundation, NALA Foundation, Evidence Action, Helen Keller Intl, and the Fred Hollows Foundation, in addition to the governments of Germany and Belgium.
These pledges will help close the funding gap needed to expedite progress towards the WHO roadmap targets which call for at least 100 countries to have eliminated at least one NTD by 2030, and to reduce by 90% the number of people requiring treatment for NTDs.
To date, 50 countries have eliminated at least one NTD and 600 million people no longer require treatment. Cases of some diseases that have plagued communities for centuries, such as Guinea worm disease and sleeping sickness, are at an all-time low.
However, climate change is affecting the reach and prevalence of infectious diseases like NTDs, threatening to erase elimination gains and stall future progress.
The commitments will help finance essential programs and treatments, support new research and innovations, and strengthen frontline health systems and workforces, among other investments.
Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, said: "In light of the pledges made today at the 2023 Reaching the Last Mile Forum, I would like to express my profound gratitude to the global community, especially the pivotal leadership role of the United Arab Emirates, led by His Highness Sheikh Mohamed bin Zayed Al Nahyan.
“This commitment is a significant stride towards eradicating, eliminating, and controlling NTDs, aligning seamlessly with the 2021- 2030 NTD road map. The collaborative efforts of countries and global donors exemplify an unwavering dedication to improving the lives of the 1.6 billion people affected by these diseases. This partnership, especially in the face of challenges posed by climate change, represents a beacon of hope and a testament to what can be achieved through united global action"
The 2023 Reaching the Last Mile Forum convened more than 450 government ministers, global health and development experts, philanthropists, and civil society leaders to galvanize concrete commitments towards mitigating the effects of the climate crisis on human health.
About Reaching the Last Mile
Reaching the Last Mile (RLM) is a portfolio of global health programs, investments, and initiatives working towards disease elimination that is driven by the philanthropy of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE. Through its partnerships and programs, RLM provides treatment and preventative care in communities that lack access to quality health services, with a focus on last-mile disease elimination.
RLM’s mission represents His Highness’s dedication to ending preventable diseases that affect the world’s most vulnerable communities, and to helping millions of children and adults live healthy, dignified lives.
About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of co-chairs Bill Gates and Melinda French Gates and the board of trustees.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Reaching the Last Mile media contacts:
Simone Elviss, GCI Health
+971 (0) 50 614 9383
Hilary Keno, GCI Health
+1 847 338 0949
Bill & Melinda Gates Foundation media contact:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Announces Grant of Employment Inducement Awards1.3.2024 22:15:00 CET | Press release
IFF (NYSE: IFF) today announced the grant of employment inducement awards to J. Erik Fyrwald, IFF Chief Executive Officer and member of the Board of Directors. The Company's Board of Directors approved the employment inducement awards on Jan. 9, 2024, with a grant date of March 1, 2024, as a material inducement to enter into an offer of employment in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08 that requires shareholder approval of equity-based compensation plans. Listing Rule 303A.08 requires the public announcement of such an award. The inducement awards will consist of (i) a target award of 68,750 performance share units (with a maximum award of 171,875 performance share units), subject to meeting the applicable performance targets set forth in the award agreement, and (ii) 56,250 restricted stock units, 100% of which will vest on the three-year anniversary of the grant date, for a maximum potential combined payout of 228,125
Whitehorse Liquidity Partners Recognized by Private Equity International’s 2023 Awards1.3.2024 16:30:00 CET | Press release
Whitehorse Liquidity Partners (together with its advisory affiliates, “Whitehorse”), a specialized investment manager focused on providing structured liquidity solutions to the alternative asset class, is pleased to announce recognition from Private Equity International (PEI) in the 2023 PEI Awards. Whitehorse placed third in the Secondaries Firm of the Year in the Americas category alongside Blackstone Strategic Partners and HarbourVest Partners and was voted Firm of the Year in Canada. “We are honoured to have been recognized again in two categories by the PEI Awards,” said Yann Robard, Managing Partner of Whitehorse. “For the fourth time among the top three Secondaries Firm of the Year in the Americas category (2018, 2020, 2022 and 2023) and the sixth time among the top three in the Firm of the Year in Canada category (2017, 2018, 2020, 2021, 2022 and 2023). You often hear us say that big is beautiful, growth is good and scale matters. Our scale has enabled us, not disrupted us. We
Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign1.3.2024 14:30:00 CET | Press release
Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. (NYSE: PVH), and Calvin Klein Fragrances, a division of Coty Inc. (NYSE: COTY), today unveil actor and musician Idris Elba and his wife, model and human rights activist Sabrina Elba as the faces of Calvin KleinETERNITY AROMATIC ESSENCE, the newest addition to the ETERNITYfragrance portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301420936/en/ Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign (Photo: Business Wire) Shot by Mert Alas, the campaign offers a fresh and impactful take on ETERNITY’s timeless dream of eternal love, capturing Idris and Sabrina in moments of intimacy set to a bespoke cover of “Fever” by FKA twigs. The striking campaign imagery is inspired by profound connection and the essence of desire, paying tribute to ETERNITY’s legacy of sensuality by partnerin
Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV1.3.2024 13:35:00 CET | Press release
The DRIPBaR, recognized as the fastest-growing IV therapy franchise in the United States, has joined forces with REVIV, the global leader in IV therapy, marking a significant milestone for the industry. The partnership creates an unrivaled offering by bringing together the specialties of two industry heavyweights boasting over 200 locations across 6 continents, with plans to add thousands more locations in the coming years. The recent surge in demand for IV therapy presents enormous opportunities globally for the companies to redefine industry standards and spearhead the next era of IV therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301173923/en/ Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire) With an extensive pipeline boasting over 450 franchisees in the United States, The DRIPBaR's decision to integrate REVIV's proprie
GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta1.3.2024 09:37:00 CET | Press release
GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern Europe, announces an exclusive distribution agreement for the cancer medicine cemiplimab in Greece, Cyprus and Malta with Regeneron Ireland DAC. Regeneron Ireland DAC is a wholly owned subsidiary of Regeneron, a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Cemiplimab is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune® technology. In the European Union, cemiplimab is indicated for adults as monotherapy treatment for certain patients with locally advanced or metastatic basal cell carcinoma (BCC), as monotherapy treatment for certain patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC), as both monotherapy o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom